openPR Logo

Press Releases from P&S Market Research- Pharmaceuticals (18 total)

Benign Prostatic Hyperplasia Therapeutics Market - Epidemiology Analysis, Therap …

The global benign prostatic hyperplasia therapeutics market is expected to witness significant growth, as increased number of effective treatments are available for cancer. Increasing awareness regarding various cancer treatment drugs, technological advancements, and growing demand for safe and effective medications are acting as the major growth drivers for the benign prostatic hyperplasia therapeutics market. Globally, regulatory bodies are adding to the growth of the market with provision of funding, grants

Global Esophageal Cancer Therapeutics Market Analysis, Development and Demand Fo …

Global esophageal cancer therapeutics market is expected to witness significant growth with an increasing awareness regarding cancer treatment and technological advancements. Also, high demand for safe and effective medications and rising prevalence of cancer are driving the growth of the global market. The regulatory bodies such as USFDA, EMA are supporting the growth of the global market by providing funding, designations and grants for speeding up the drug development process. Explore

Pancreatic Cancer Therapeutics Market - Epidemiology Analysis, Therapy, Developm …

The global pancreatic cancer therapeutics market holds numerous opportunities for the key players, as pancreatic cancer is a highly challenging disease among all types of cancer, which has no specific treatment available for it, as of now. Also, growing incidence of cancer and technological advancements are supporting the growth of the global pancreatic cancer therapeutics market growth. Explore Report at: Cancer instigates uncountable growth of cells due to some abnormalities

Novel Targets for Breast Cancer Treatment Drive Estrogen Receptor-Positive (ER+) …

Estrogen Receptor-Positive (ER+) breast cancer currently exhibits a pipeline with 46 active drug candidates. ER+ breast cancer pipeline offers novel therapeutic targets for the treatment of breast cancer The study analyzed that the estrogen receptor positive breast cancer pipeline comprises approximately 74 drug candidates, of which nine products are in Phase III, 16 products in Phase II, 18 products in Phase I, and three products are in Pre-Clinical stage. The development of

Serine/Threonine-Protein Kinase Inhibitors Pipeline Analysis, 2016

Serine/threonine-protein kinases (EC are enzyme or protein that has hydroxyl (OH) group in the side chain. Phosphorylation in serine or threonine residues may cause changes in the function of the target protein. Those drugs/ligands that inhibit phosphorylating activity of these kinases are called serine/threonine protein kinases inhibitors. Serine/threonine kinase receptors are a family of transmembrane receptors containing intracellular serine/threonine kinase domains that respond to a few cytokines including the

Increasing prevalence of cancer drives Global Cancer/Tumor Profiling Market

Increasing prevalence of cancer drives the global market According to the study, the global cancer/tumor profiling market is likely to grow significantly, during the forecast period, due to increasing prevalence of cancer, growing government funding for research activities and increasing usage of biomarkers. The market is further expected to gain revenue, owing to increased focus on personalized medicine, availability of tailored medical treatment to suit individual characteristics, needs and preferences of

BACE Inhibitors Exhibit an Emerging Pipeline with 10+ Drug Candidates

BACE inhibitors offer novel therapeutic approach for the treatment of Alzheimer’s disease The study analyzed that the Beta Secretase inhibitors pipeline comprised 15 drug candidates, of which three products are in Phase III, three products in Phase II, one product in Phase I, and one product is in Discovery. The development of two BACE inhibitor candidates was found to be inactive, and five products were discontinued. BACE is a cleaving enzyme

BET Inhibitors Exhibit an Emerging Pipeline with 35+ Drug Candidates

BET inhibitors currently exhibit a strong pipeline with estimated 38 drug candidates. BET inhibitors offer novel therapeutic approach for cancer The study analyzed that the BET inhibitors pipeline comprised 38 drug candidates, of which 19 were in Pre-Clinical stage of development. The high prevalence of cancer across the globe fuels the extensive research and development for BET inhibitors. BET inhibitor constitutes that class of drugs, which prevents interactions between BET proteins, and

Vasomotor Symptoms of Menopause Therapeutics Pipeline Analysis, 2016

Vasomotor symptoms occur when a woman reach the state of menopause and ovaries stop producing eggs, and there is a reduction in secretion of hormones such as estrogen and progesterone. It usually occurs naturally, most often between age of 45 years to 51 years. The women feel perimenopausal transition that generally occurs prior to cessation of menstruation. During perimenopausal transition, the menstruation cycle becomes erratic, leading to irregular menses, heavy

Interstitial Cystitis (IC) Disease Pipeline Analysis by P&S Market Research

Interstitial Cystitis (IC) is a painful bladder syndrome in which inflamed and irritated bladder cause recurring discomfort or pain. The symptoms of IC include an urgent or frequent need to urinate and pain during bladder filling. Women are more prone to develop this condition. Pain may be mild or so severe as to be debilitating and it can vary from day to day. IC is categorized into non-ulcerative and ulcerative.

Phosphoinositide 3-Kinase Inhibitor Pipeline Analysis, 2016 by P&S Market Resear …

Phosphoinositide 3-kinase (PI3K) pathway regulates a number of processes such as cell growth, metabolism, survival, cell migration, protein synthesis, metabolism and proliferation. It also plays a critical role in human malignancy. Overexpressed and aberrantly activated PI3K leads to many human diseases including cancer, inflammation, and cardiovascular disease. PI3K inhibitor inhibits the action of aberrantly activated PI3K. PI3K are lipid kinase enzymes of approximately 200–300 kDa in molecular weight. It has

Lysosomal Storage Disorders Pipeline Analysis, 2016 by P&S Market Research

The deficiency of lysosomal enzymes cause lysosomal storage disorders (LSDs). It occurs due to mutations of genes that encode proteins, enzyme and related cofactors. There are approximately 50 types of LSDs. LSDs such as Gaucher disease, Fabry disease, Niemann-Pick disease, Pompe disease, Hunter syndrome, Mucopolysaccharidosis type III, Metachromatic leukodystrophy, Tay-Sachs disease and Batten disease affect different parts of body including brain, heart, skeleton, skin and central nervous system. The LSDs pipeline

Janus Kinase (JAK) Inhibitors Pipeline Analysis, 2016 by P&S Market Research

Janus kinase (JAK) inhibitors block Janus kinase activator enzymes and interrupt signaling pathway. It plays an important role in host defense, oncology, autoimmunity and hematological cancers, which makes them an important target for therapeutics. Many signal transduction pathways are done by JAK activity for the normal signaling. The abnormal aberration in JAKs activity can lead to diseased state. For instance, over activation of JAK can lead to tumorigenesis whereas loss

Hepcidin antagonist, Pipeline Analysis, 2016 by P&S Market Research

Hepcidin is a small peptide which acts as iron regulatory hormone. The name ‘hepcidin’ is taken from the place of synthesis in hepatocytes (hep), whereas cidin denotes its antimicrobial activity. Liver is the key organ that secrete hepcidin and regulates iron hormone. Hepcidin was initially observed in human urine sample and in human blood ultrafiltrate as a small bactericidal peptide (defensin and cathelicidin) and now it is known as liver–expressed

Fungal Infections Pipeline Analysis, 2016 by P&S Market Research

Fungal Infection is a major cause of morbidity worldwide. Fungal Infections are caused by different fungi found in environment. Although, some fungi are not dangerous at all but few types of fungi are harmful to health. It involves the invasion of tissue such as skin and lung by specific type of fungi. According to Centers for Disease Control and Prevention (CDC), a public health institute in the U.S., approximately 1.5

Estrogen Receptor-Positive Breast Cancer Pipeline Analysis, 2016

Estrogen receptor-positive breast cancer is the most common female cancer globally. Cancer that is positive for estrogen-receptor are called estrogen receptor (ER) -positive cancer. It receives signals from estrogen hormone that could promote cell growth. Breast is made up of fatty, connective and lymphatic tissues, and various tiny glands called lobules. In breast cancer, cells grow in uncontrollable manner and they form tumor which can be felt as a lump

AKT/Protein Kinase B (PKB) Inhibitors Pipeline Analysis, 2016 by P&S Market Rese …

AKT, also known as Protein Kinase B (PKB), is overexpressed or activated in large number of human cancers, including breast, lung, gastric, ovary and pancreas. AKT inhibitor inhibits the activated form of AKT that leads to normal functioning of AKT kinases. AKT has three isoforms; AKT1, AKT2 and AKT3, which play an important role in regulation of diverse cellular functions such as metabolism, motility, cell survival, cell-cycle progression and transcription.

Idiopathic Pulmonary Fibrosis (IPF) Pipeline, A Novel Advancement for the Treatm …

The study analyzed that the IPF pipeline comprised of 97 therapeutic candidates, of which 15 are in Phase II stage of development. The lack of complete cure for IPF fuels the extensive research and development for the IPF therapeutic. Various drugs are being developed as novel and promising therapeutics for the treatment of IPF. Browse the Report Summary at: Insights on pipeline segments As per the findings of research, it was found

Go To Page:   1 2 3 4 5 6 7 8 9 10